Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Sander Tuit

3PUBLICATIONS

27CO-AUTHORS

Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|May 19, 2025

TCR-Based Therapy Directed against Kallikrein-Related Peptidase 4 Is Safe and Effective against Prostate Cancer.

Rosa A van Amerongen, Sander Tuit, Dennis F G Remst

|Aug 31, 2022

A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease.

Astrid G S van Halteren, Jessica S Suwandi, Sander Tuit

|Jan 27, 2017

Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages.

Rob J W Arts, Theo S Plantinga, Sander Tuit

Pageof 1

Frequent Collaborators

1 joint publications

Rob J W Arts

1 joint publications

Theo S Plantinga

1 joint publications

Thomas Ulas

1 joint publications

Gosse J Adema

1 joint publications

Leo A B Joosten

1 joint publications

Mihai G Netea

1 joint publications

Joachim L Schultze

1 joint publications

Romana T Netea-Maier

1 joint publications

Astrid G S van Halteren

1 joint publications

Sandra Laban

Frequent Collaborators

1 joint publications

Rob J W Arts

1 joint publications

Theo S Plantinga

1 joint publications

Thomas Ulas

1 joint publications

Gosse J Adema

Top Related Videos

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on : Sep 03, 2013

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on : Oct 31, 2012

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line

Published on : Aug 02, 2021

See more related videos

Top Related Videos

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on : Sep 03, 2013

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on : Oct 31, 2012

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line

Published on : Aug 02, 2021

See more related videos